Alderley Park is to host a major UK conference to explore the strengths in the discovery, development and manufacture of cancer medicines in the North of England.
The one-day event, which is billed as Accelerating Cancer Drug Development – From Target to Patients has been organised by Bionow, the North of England life science industry group, and takes place at the Alderley Park Conference Centre on February 27.
It will highlight industry, academic and clinical contributions made by the region whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.
The programme features a broad range of renowned businesses and organisations working to improve patient outcomes, including The Christie Hospital, Manchester – the largest single site cancer centre in Europe, which treats more than 44,000 patients a year.
One of the two keynote addresses will be given by Professor Rob Bristow, a world authority on prostate cancer who took over as director of the University of Manchester’s Manchester Cancer Research Centre (MCRC) last year.
Dr Susan Galbraith, vice president of oncology at AstraZeneca, which developed a breakthrough lung cancer drug Tagrisso with one of the fastest development programmes in pharmaceutical history, will also address the conference.
Read more at thebusinessdesk.com